Cancer-related fatigue

causes and current treatment options

Melissa S. Y. Thong (Avtor), Cornelis J. F. van Noorden (Avtor), Karen Steindorf (Avtor), Volker Arndt (Avtor)

Povzetek

Fatigue is a symptom commonly experienced by survivors of cancer through all stages of the disease trajectory. Survivors identify fatigue as a significant problem which is not adequately addressed by healthcare providers [1•]. Being fatigued has a greater negative impact on functioning and health-related quality of life (HRQoL) than other symptoms such as pain or depression [2, 3]. Fatigued survivors are more likely to have reduced employment participation [4, 5], greater financial stress [6], and higher healthcare utilization [6, 7]. Moreover, fatigue may reduce survival; feeling fatigued at diagnosis [6, 8] and during survivorship [9] is associated with higher mortality. This review aims to provide a summary on the current state of research on cancer-related fatigue (CRF) of survivors with local disease treated with curative intent. We briefly summarize the prevalence, definition, evaluation, and etiology of CRF. Due to the volume of research on CRF treatments, we provide a non-exhaustive overview of treatments for CRF published within the last 5 years (guidelines, meta-analyses, reviews, randomized trials).

Ključne besede

cancer-related fatigue;cytokines;physical activity;pharmacologic;complementary and alternative medicine;

Podatki

Jezik:	Angleški jezik
Leto izida:	2020
Tipologija:	1.01 - Izvirni znanstveni članek
Organizacija:	NIB - Nacionalni inštitut za biologijo
UDK:	577
COBISS:	5310543
ISSN:	1534-6277
Št. ogledov:	25
Št. prenosov:	13
Ocena:	0 (0 glasov)
Metapodatki:

Ostali podatki

Komentar vira:	Nasl. z nasl. zaslona; Opis vira z dne 7. 2. 2020;
Strani:	str. 1-19
Letnik:	ǂVol. ǂ21
Zvezek:	ǂiss. ǂ2
Čas izdaje:	2020
DOI:	10.1007/s11864-020-0707-5
ID:	24556034